This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Fadrozole
DrugBank Accession Number
DB16832
Background

Not Available

Type
Small Molecule
Groups
Investigational
Structure
Weight
Average: 223.279
Monoisotopic: 223.110947431
Chemical Formula
C14H13N3
Synonyms
  • Fadrozole
External IDs
  • CGS 16949A
  • CGS-16949A
  • CGS16949A

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
H3988M64PU
CAS number
102676-47-1
InChI Key
CLPFFLWZZBQMAO-UHFFFAOYSA-N
InChI
InChI=1S/C14H13N3/c15-8-11-4-6-12(7-5-11)14-3-1-2-13-9-16-10-17(13)14/h4-7,9-10,14H,1-3H2
IUPAC Name
4-{5H,6H,7H,8H-imidazo[1,5-a]pyridin-5-yl}benzonitrile
SMILES
N#CC1=CC=C(C=C1)C1CCCC2=CN=CN12

References

General References
Not Available
Human Metabolome Database
HMDB0252157
ChemSpider
53850
BindingDB
8611
ChEBI
94355
ChEMBL
CHEMBL9298
Wikipedia
Fadrozole

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.343 mg/mLALOGPS
logP2.5ALOGPS
logP2.41Chemaxon
logS-2.8ALOGPS
pKa (Strongest Basic)6.87Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area41.61 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity66.46 m3·mol-1Chemaxon
Polarizability24.24 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created at July 18, 2022 15:55 / Updated at December 01, 2022 11:31